Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Treatment symbols : Abbv save search
AbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant (QULIPTA®) for Preventive Treatment of Migraine
Published: 2024-04-12 (Crawled : 13:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -1.92%
H: 0.0%
C: 0.0%
qulipta abbvie treatment for migraine
Myopia and presbyopia treatment market size to grow by USD 7.94 billion from 2022 to 2027, Major Vendors include AbbVie Inc., Alcon Inc. and Arctic Vision, Technavio
Published: 2024-02-28 (Crawled : 17:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -1.4%
H: 0.0%
C: -0.01%
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
|
| O: 0.11%
H: 2.23%
C: 0.11%
ALC | $79.55 1.38% -0.25% 1.1M
|
Health Technology
|
| O: 4.09%
H: 1.72%
C: 1.41%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.6%
H: 0.02%
C: -1.03%
abbvie presbyopia treatment market
AbbVie and OSE Immunotherapeutics Announce Partnership to Develop a Novel Monoclonal Antibody for the Treatment of Chronic Inflammation
Published: 2024-02-28 (Crawled : 06:00) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.6%
H: 0.02%
C: -1.03%
partnership abbvie antibody treatment
Global Epidural Abscess Treatment Market Report 2024 - Treatment Advances and Digital Health Technologies Shaping the Future of Epidural Abscess Care
Published: 2024-02-12 (Crawled : 15:30) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -0.57%
H: 0.04%
C: -1.74%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -1.46%
H: 1.04%
C: 0.97%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: -0.48%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.02%
H: 0.46%
C: -0.14%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.83%
H: 0.7%
C: -0.27%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.64%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.86%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -1.77%
H: 0.46%
C: 0.41%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.4%
H: 1.6%
C: 1.54%
report health treatment care global market
New Data for Bispecific Antibody Epcoritamab (DuoBody® CD3xCD20) Shows Strong, Durable Treatment Response for Patients with Difficult-To-Treat Relapsed/Refractory (R/R) Follicular Lymphoma (FL)
Published: 2023-12-09 (Crawled : 20:20) - prnewswire.com
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
| Email alert
Add to watchlist
CERE | $42.15 0.02% 0.02% 810K
|
Finance
| Email alert
Add to watchlist
GNMSF | $290.38 3.83% 220
|
Health Technology
| Email alert
Add to watchlist
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
| Email alert
Add to watchlist
cd20 duobody antibody treatment response
AbbVie Announces U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) Updates for Epcoritamab (EPKINLY®/TEPKINLY®) for the Treatment of Relapsed/Refractory Follicular Lymphoma
Published: 2023-11-27 (Crawled : 12:00) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
epkinly drug abbvie food treatment
Global Thyroid Gland Disorder Treatment Market Set to Reach USD 3.15 Billion by 2030, Reveals Infinium Global Research
Published: 2023-11-03 (Crawled : 09:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.88%
H: 3.51%
C: 2.73%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -1.4%
H: 0.42%
C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 1.88%
H: 0.0%
C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 2.0%
H: 0.0%
C: 0.0%
reach treatment thyroid research global set market
Kadcyla Leads the Global Antibody Drug Conjugates Market with Extensive Use in Breast Cancer Treatment
Published: 2023-11-01 (Crawled : 18:00) - prnewswire.com
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: -1.46%
H: 3.67%
C: 3.26%
ZYME | $8.85 2.08% 2.03% 550K
|
Health Technology
|
| O: 1.14%
H: 0.42%
C: -0.7%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 1.03%
H: 0.73%
C: 0.58%
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
|
| O: -0.16%
H: 6.42%
C: 4.49%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.86%
H: 0.0%
C: 0.0%
STRO | $3.635 -3.58% -3.71% 520K
|
Health Technology
|
| O: 0.39%
H: 3.86%
C: 3.86%
IMGN | $31.23 0.03% 49M
|
Health Technology
|
| O: 5.09%
H: 5.48%
C: -1.27%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.47%
H: 1.88%
C: 1.78%
EXEL | $22.51 0.09% 0.09% 2.3M
|
Health Technology
|
| O: -2.62%
H: 1.17%
C: -1.66%
drug antibody breast cancer treatment global market
Allergan Aesthetics Announces Positive Topline Results from Two Pivotal Phase 3 Studies of TrenibotulinumtoxinE (BoNT/E) for the Treatment of Glabellar Lines
Published: 2023-10-24 (Crawled : 13:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
positive treatment topline results
The Thyroid Gland Disorder Treatment Market to grow by USD 868.87 million from 2022 to 2027 | Abbott Laboratories, AbbVie Inc., Alvogen Iceland ehf, and more among key companies- Technavio
Published: 2023-09-25 (Crawled : 03:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.81%
H: 1.63%
C: -1.03%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 3.72%
H: 0.0%
C: 0.0%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.21%
H: 1.14%
C: 1.04%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.31%
H: 0.98%
C: 0.97%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.13%
H: 0.91%
C: 0.88%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.24%
H: 0.0%
C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -1.17%
H: 0.0%
C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.06%
H: 0.1%
C: -0.25%
abbvie treatment thyroid market
Leading Players Pfizer, AbbVie, and Novartis at the Forefront of Advancements in Plaque Psoriasis Treatment
Published: 2023-09-20 (Crawled : 22:00) - prnewswire.com
UCBJY | $63.676 -4.38% 7.2K
|
Manufacturing
|
| O: -0.79%
H: 0.0%
C: -1.26%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.7%
H: 0.06%
C: -0.75%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -1.47%
H: 0.0%
C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.04%
H: 0.76%
C: -0.16%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.16%
H: 0.0%
C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.22%
H: 0.15%
C: -0.98%
psoriasis treatment novartis
Myasthenia Gravis Treatment Market to Grow Exponentially by 2029 | Brandessence Market Research
Published: 2023-09-18 (Crawled : 14:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 2.7%
H: 0.0%
C: -5.11%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.72%
H: 0.13%
C: -0.93%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.02%
H: 0.18%
C: -0.78%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.06%
H: 0.44%
C: -0.64%
treatment research market
Myopia and presbyopia treatment market to grow by USD 7.94 billion from 2022 to 2027 | Asia to account for 37% of market growth- Technavio
Published: 2023-09-18 (Crawled : 05:00) - prnewswire.com
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
|
| O: -1.06%
H: 0.59%
C: -0.71%
ALC | $79.55 1.38% -0.25% 1.1M
|
Health Technology
|
| O: -0.85%
H: 0.38%
C: -0.06%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
presbyopia treatment asia market
Optic Nerves Disorder Treatment Market Rises: North America Takes the Helm
Published: 2023-09-14 (Crawled : 00:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.84%
H: 0.0%
C: 0.0%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.47%
H: 0.41%
C: -0.26%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.28%
H: 1.0%
C: 0.76%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 1.78%
H: 1.76%
C: 1.07%
america treatment market
Journal of Cosmetic Dermatology Publishes Data Demonstrating Patient Satisfaction with Natural-Looking Outcomes Following Treatment with OnabotulinumtoxinA (BOTOX® Cosmetic)
Published: 2023-08-30 (Crawled : 15:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
botox treatment
Global Obesity Treatment Market Poised to Reach $26.44 Billion by 2028, Fueled by Rising Prevalence and Innovative Interventions
Published: 2023-08-25 (Crawled : 02:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.06%
H: 1.52%
C: 0.66%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.34%
H: 1.29%
C: 0.93%
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: -0.98%
H: 1.19%
C: 0.82%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.51%
H: 0.0%
C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.11%
H: 0.44%
C: -0.22%
obesity reach treatment global market
Global Autoimmune Treatment Market Soars to $288.32 Billion by 2028, Driven by a 7.72% CAGR from 2023
Published: 2023-08-25 (Crawled : 02:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -3.27%
H: 3.65%
C: 3.36%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: -4.14%
H: 5.37%
C: 4.39%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.67%
H: 0.37%
C: 0.26%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.51%
H: 0.0%
C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.11%
H: 0.44%
C: -0.22%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.73%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.22%
H: 0.6%
C: 0.31%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.19%
H: 0.25%
C: -0.28%
treatment global market
AbbVie Announces European Commission Approval of AQUIPTA® (atogepant) for the Preventive Treatment of Migraine in Adults
Published: 2023-08-17 (Crawled : 06:00) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.87%
H: 0.49%
C: -0.75%
aquipta abbvie approval treatment migraine
Global Biosimilars Market Analysis 2023 - 2030: Delivering Accessible Treatment Options and the Future of Healthcare
Published: 2023-08-16 (Crawled : 01:00) - prnewswire.com
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.99%
H: 1.45%
C: 1.36%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.56%
H: 0.0%
C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 2.02%
H: 0.72%
C: -0.49%
treatment global market
Environmental Factors and Advancements in Immunotherapies Propel Growth of Global Allergy Treatment Market to 2027
Published: 2023-08-10 (Crawled : 10:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.63%
H: 0.0%
C: -2.67%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 2.5%
H: 0.0%
C: -0.11%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.13%
H: 0.72%
C: -0.18%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.75%
H: 1.13%
C: -1.05%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.0%
H: 0.61%
C: -0.28%
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
|
| O: -0.23%
H: 1.22%
C: -2.21%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.41%
H: 1.08%
C: 0.16%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.52%
H: 1.05%
C: 0.47%
propel treatment global growth market
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.